The effect of Mesalazine and Nortriptyline on Patients with Irritable Bowel Syndrome with Diarrhea: A Randomized Clinical Trail

Authors

  • Hamid Vahedi 1 1. Dept. of Gastroenterology, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Seyed Abbas Mousavi 2* 2. Research Center of Psychiatry, Golestan University of Medical Sciences, Golestan, Iran.
  • Shima Gholamzadeh 3 3. Shahroud Islamic Azad University, Shahroud, Iran.
  • Ahmad Khosravi 4** 4. Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.

DOI:

https://doi.org/10.22100/ijhs.v3i1.194

Keywords:

Mesalazine, Nortriptyline, Irritable bowel syndrome, Abdominal pain.

Abstract

Background: The objective of this randomized trial was to compare the effects of mesalazine and nortriptyline on relief of abdominal pain, discomfort, abnormal bowel habits and quality of life in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).

Methods: In this triple blinded, randomized clinical trial, 44 patients with irritable bowel syndrome with diarrhea were randomly assigned to receive mesalazine (500 mg tablet orally, twice a day) or nortriptyline (10 mg tablet orally, once daily). IBS-D was diagnosed according to the Rome Ⅲ criteria. Before allocation, all patients completed the Beck questionnaire for screening for depression, and the informed consent form.

Results: Change score for abdominal pain severity was significantly higher for mesalazine than for nortriptyline (208.5±80.9 V.s 146.8±105.6) and change score for days with pain was not significantly different between two arms (3.9±2.8 V.s 2.8±3.0). The results show that the change score of satisfaction with bowel habits (56.2±20.2 V.s 37.5±24.9) and quality of life (42.0±26.7 V.s 26.3±18.6) in the mesalazine-treated group is greater than in the nortriptyline group.

Conclusions: This study showed that mesalazine, as an anti-inflammatory agent for treatment of IBS-D in patients without psychological disorders, is more effective than nortriptyline.

Downloads

Published

2017-01-01

Issue

Section

Articles

How to Cite

The effect of Mesalazine and Nortriptyline on Patients with Irritable Bowel Syndrome with Diarrhea: A Randomized Clinical Trail. (2017). International Journal of Health Studies (Undergoing Change to Shahroud Journal of Medical Sciences), 3(1). https://doi.org/10.22100/ijhs.v3i1.194